𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9249 Single vs double dose palonosetron for the prevention of acute and delayed nausea and vomiting in patients undergoing high dose chemotherapy and autologous stem cell transplantation

✍ Scribed by Marcacci, G.; Becchimanzi, C.; Arcamone, M.; Capobianco, G.; Corazzelli, G.; Frigeri, F.; Russo, F.; Pinto, A.

Book ID
121973788
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
67 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Randomized, placebo-controlled, pilot st
Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting
✍ Jon D. Herrington; Adam D. Jaskiewicz; Juhee Song πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract ## BACKGROUND. The combination of palonosetron and aprepitant is safe and effective in the prevention of chemotherapy‐induced emesis (CIE). The purpose of this pilot study was to ascertain the effectiveness of 1‐day versus 3‐day aprepitant in the prevention of acute and delayed nausea

Prolonged nausea and vomiting after high
Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinoma
✍ J. Randolph Hecht; Tony Lembo; Linnea Chap πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

vomiting after high dose chemotherapy with autologous peripheral stem cell transplantation (PSCT) in the treatment of high risk breast carcinoma patients. 1 Division of Digestive Diseases, Department of METHODS. Patients with high risk breast carcinoma were conditioned with high